Table 1:

Patient characteristics in RNA sequencing and gene validation cohorts

	RNA Sequencing	qPCR Validation
	n = 43	n = 12
Sex
Male	19	6
Female	24	6
Median age (range, years)	65.9 (40.9–91.0)	62.8 (54.2–90.9)
Median follow-up (years)	6.1	2.5
Node positive disease (%)	31 (72.1%)	9 (75%)
Grade 1 (%)	11 (25.6%)	2 (16.7%)
Grade 2 (%)	32 (74.4%)	9 (75%)
Grade 3 (%)*	-	1 (8.3)
PFS (median, years)	3.2	3.5

Progression-free survival (PFS);

^*well-differentiated